ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0052

HLA-B27 Is Associated with Altered Mucosal IgA Response to Oral and Fecal Microbiota in Patients with Axial Spondyloarthritis

Tejpal Gill1, Patrick Stauffer1, Mark Asquith1, Ted Laderas1, Tammy Martin2, Sean Davin1, Claire Ramirez1, Ingrid Lindquist1, Justine Nguyen1, stephen Planck1, Carley Shaut1, Sarah Diamond1, James T. Rosenbaum3 and Lisa Karstens1, 1Oregon Health & Science University, Portland, OR, 2Departments of Ophthalmology, and Molecular Microbiology & Immunology, Oregon Health & Sciences University, Portland, OR, 3Departments of Ophthalmology, Medicine, and Cell Biology, Oregon Health & Sciences University and Chair Emeritus, Legacy Devers Eye Institute, Portland, OR

Meeting: ACR Convergence 2021

Keywords: axial spondyloarthritis, gut microbiome, HLA B27, IgA sequencing, oral microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Spondyloarthritis Including PsA – Basic Science Poster (0046–0068)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Axial spondyloarthritis (AxSpA) is immune-mediated inflammatory arthritis, which affects the sacroiliac and spinal joints, and is associated with gut inflammation. Disease pathogenesis is associated with host genetics (HLA-B27), environmental factors, and gut microbial dysbiosis. Previous studies have shown HLA-B27-associated microbial dysbiosis in ankylosing spondylitis patients as well in experimental models of spondyloarthritis. However, not all microbial changes might drive the chronic inflammatory response or elicit host IgA responses. Here, we report the presence of specific IgA-coated microbes that may be disease contributors in AxSpA patients.

Methods: Microbial community structure and IgA coating from feces and saliva samples from AxSpA patients (n=17) and healthy controls (n=12-14) were determined by 16S rRNA sequencing (16S sequencing) and IgA sequencing (IgA-SEQ) respectively. IgA-SEQ involves sorting IgA-coated microbes using flow cytometry and performing 16S sequencing on the IgA positive and negative fractions. Correlation analyses were performed to determine the disease association between IgA-coated microbes in AxSpA patients and the disease activity score. Furthermore, metagenomic contribution of IgA positive and negative microbes was estimated by using the bioinformatic tool PICRUSt2

Results: 16S sequencing of oral and fecal microbiota showed distinct microbial community composition in AxSpA patients as compared with the healthy controls. AxSpA patients showed a significant decrease in oral microbial diversity, whereas the decrease in fecal microbial diversity was not significant. However, the lack of microbial differences in diversity in fecal samples did not suggest a lack of immunological impact of the gut microbes. AxSpA patients had many microbes at a genus level with increased IgA coating (e.g., Akkermansia, Klebsiella, Ruminococcus, Lachnospira, Pseudomonas) in comparison with the healthy controls. Despite significant changes in microbial diversity in the saliva of AxSpA patients, only a few microbes such as Prevotellaceae, NK3831 group, and Alloprevotella were enriched in IgA coating. We also found a positive correlation between IgA-coated Clostridium Family XIII and the disease activity. Predictive metagenomic analysis of IgA coated microbes showed perturbation of pathways belonging to propanoate and glutathione metabolism, biosynthesis of secondary metabolites, and bacterial secretion system in AxSpA patients. Analysis of individual genes showed the alterations of the genes belonging to the tryptophan and butanoate pathways, further emphasizing the importance of IgA coating in targeting immune responsive bacteria.

Conclusion: We show that the immune response to oral and fecal microbes is altered in AxSpA patients, with IgA coated Clostridium positively correlating with disease activity. Predictive metagenome analysis revealed perturbations of metabolic and oxidative stress-related pathways in AxSpA patients. Taken together, our results suggest that HLA-B27-associated increase in IgA coated microbes may indicate an aberrant immune response to gut commensal microbes, which may contribute to the development of AxSpA.


Disclosures: T. Gill, None; P. Stauffer, None; M. Asquith, None; T. Laderas, None; T. Martin, None; S. Davin, None; C. Ramirez, None; I. Lindquist, None; J. Nguyen, None; s. Planck, None; C. Shaut, None; S. Diamond, None; J. Rosenbaum, AbbVie, 2, UCB, 2, Novartis, 2, Gilead, 2, Corvus, 2, Roivant, 2, Revolo, 2, Neoleukin, 2, Affibody, 2, Santen, 2, Celgene, 2, Bristol Myers, 2, Pfizer, 5, Horizon, 5, UpToDate, 9; L. Karstens, None.

To cite this abstract in AMA style:

Gill T, Stauffer P, Asquith M, Laderas T, Martin T, Davin S, Ramirez C, Lindquist I, Nguyen J, Planck s, Shaut C, Diamond S, Rosenbaum J, Karstens L. HLA-B27 Is Associated with Altered Mucosal IgA Response to Oral and Fecal Microbiota in Patients with Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/hla-b27-is-associated-with-altered-mucosal-iga-response-to-oral-and-fecal-microbiota-in-patients-with-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hla-b27-is-associated-with-altered-mucosal-iga-response-to-oral-and-fecal-microbiota-in-patients-with-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology